QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)
QQQ   427.32 (-0.75%)
AAPL   181.56 (-0.41%)
MSFT   402.79 (-0.31%)
META   471.75 (-0.33%)
GOOGL   141.12 (+0.43%)
AMZN   167.08 (-1.43%)
TSLA   193.76 (-3.10%)
NVDA   694.52 (-4.35%)
NIO   5.96 (-2.93%)
AMD   165.69 (-4.70%)
BABA   73.15 (-1.03%)
T   16.92 (-0.29%)
F   12.26 (-0.33%)
MU   80.71 (+1.52%)
CGC   3.54 (-7.33%)
GE   148.62 (-0.36%)
DIS   109.44 (-1.94%)
AMC   4.67 (-3.52%)
PFE   27.60 (-0.07%)
PYPL   58.63 (-0.86%)
XOM   102.75 (-0.94%)

Eloxx Pharmaceuticals (ELOX) News Today

$0.76
0.00 (0.00%)
(As of 02/20/2024 ET)
SourceHeadline
barrons.com logoVertex Pharmaceuticals Inc.
barrons.com - February 16 at 11:44 PM
finance.yahoo.com logoEloxx Pharmaceuticals, Inc. (ELOX)
finance.yahoo.com - February 6 at 10:48 AM
msn.com logoCNS Pharmaceuticals prices $4M public offering
msn.com - January 30 at 5:44 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Regeneron (REGN)
markets.businessinsider.com - December 23 at 9:39 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Shockwave Medical (SWAV), Annexon Biosciences (ANNX) and United Therapeutics (UTHR)
markets.businessinsider.com - December 21 at 8:22 PM
finance.yahoo.com logoOff the Beaten Path: 3 Delisted Stocks for The Speculative Investor
finance.yahoo.com - December 13 at 2:31 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Lumos Pharma (LUMO), Crispr Therapeutics AG (CRSP) and Biomea Fusion (BMEA)
markets.businessinsider.com - December 11 at 11:19 PM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Biomea Fusion (BMEA) and Medtronic (MDT)
markets.businessinsider.com - November 22 at 8:35 PM
msn.com logoHoth stock jumps on positive FDA feedback on drug HT-KIT
msn.com - November 14 at 9:57 AM
finance.yahoo.com logoEloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update
finance.yahoo.com - November 13 at 4:38 PM
morningstar.com logoEloxx Pharmaceuticals Inc ELOX
morningstar.com - November 8 at 1:14 AM
finance.yahoo.com logoEloxx Pharmaceuticals Reports Additional Confirmation that All Nonsense Mutation Alport Syndrome Patients Treated with ELX-02 in Phase 2 Study had Improvement in Kidney Morphology and Clinical Benefit of Reduction or Stabilization of Proteinuria
finance.yahoo.com - October 9 at 8:59 AM
seekingalpha.com logoEloxx Pharmaceuticals prices $2M stock offering
seekingalpha.com - September 21 at 5:48 PM
markets.businessinsider.com logoEloxx Pharmaceuticals Announces Registered Direct Offering - Quick Facts
markets.businessinsider.com - September 19 at 9:35 AM
finance.yahoo.com logoEloxx Pharmaceuticals Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
finance.yahoo.com - September 19 at 9:35 AM
finance.yahoo.com logoEloxx Pharmaceuticals Reports Independent Confirmation of Positive Biopsy Results in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
finance.yahoo.com - September 18 at 8:52 AM
msn.com logoEloxx moves ahead with plans with gene therapy for rare kidney disorder
msn.com - September 8 at 3:43 PM
finance.yahoo.com logoEloxx Pharmaceuticals Provides Program Updates on ELX-02 and ZKN-013
finance.yahoo.com - September 7 at 9:34 AM
fool.com logoEloxx Pharmaceuticals (NASDAQ: ELOX)
fool.com - August 30 at 2:14 PM
msn.com logoEloxx reports all patients in Phase II Alport syndrome trial have improved
msn.com - August 15 at 7:27 AM
markets.businessinsider.com logoEloxx Pharmaceuticals Reports Second Quarter 2023 Financial and Operating Results and Provides Business Update
markets.businessinsider.com - August 14 at 9:25 PM
finance.yahoo.com logoEloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
finance.yahoo.com - August 14 at 11:23 AM
msn.com logoEloxx Pharma (NASDAQ:ELOX) Rises On Promising Phase 2 Data In Alport Syndrome
msn.com - August 14 at 11:23 AM
finance.yahoo.com logoEloxx Pharmaceuticals Reports Drug Response in All Patients Treated with ELX-02 in Phase 2 Clinical Study for Alport Syndrome
finance.yahoo.com - August 14 at 11:23 AM
marketbeat.com logoThis Small Cap Stock Surged Over 100%
marketbeat.com - July 12 at 10:52 AM
msn.com logoEloxx, Airbnb, Tesla, PainReform, Roku: Why These 5 Stocks Are Drawing Investor Attention Today
msn.com - July 11 at 11:06 PM
benzinga.com logoEloxx Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 111.3%
benzinga.com - July 11 at 6:05 PM
msn.com logoOppenheimer Maintains Eloxx Pharmaceuticals (ELOX) Outperform Recommendation
msn.com - July 11 at 3:48 PM
marketbeat.com logo
marketbeat.com - July 11 at 3:17 PM
benzinga.com logoWhy Eloxx Pharmaceuticals (ELOX) Stock Is Soaring Tuesday
benzinga.com - July 11 at 1:04 PM
benzinga.com logoOppenheimer Maintains Outperform on Eloxx Pharmaceuticals, Raises Price Target to $55
benzinga.com - July 11 at 10:47 AM
marketbeat.com logo
marketbeat.com - July 11 at 10:44 AM
marketbeat.com logo
marketbeat.com - July 11 at 9:41 AM
finance.yahoo.com logoEloxx Pharmaceuticals Announces Publication Demonstrating the Power of its TURBO-ZM™ Platform to Target the Human Ribosome for Therapeutic Benefit
finance.yahoo.com - July 10 at 10:08 AM
finance.yahoo.com logoEloxx Pharmaceuticals Key Opinion Leader Event Highlights Significant Unmet Need in Treatment of Alport Syndrome Patients with Nonsense Mutations and Additional Positive Results from Phase 2 Clinical Study Evaluating ELX-02
finance.yahoo.com - June 28 at 9:43 AM
finance.yahoo.com logoEloxx Pharmaceuticals to Host Investor and Analyst Call on Alport Syndrome
finance.yahoo.com - June 21 at 2:28 PM
finance.yahoo.com logoEloxx Pharmaceuticals Highlights Recent Alport Syndrome Natural History Data Presented at 60th ERA Congress
finance.yahoo.com - June 21 at 9:27 AM
benzinga.com logoFinal Data Report: Eloxx Touts Improved Lung Function For Cystic Fibrosis Candidate
benzinga.com - June 15 at 12:32 PM
finance.yahoo.com logoEloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients
finance.yahoo.com - June 14 at 6:51 PM
msn.com logoNasdaq grants extension to Eloxx Pharmaceuticals to regain compliance
msn.com - June 6 at 9:48 AM
finance.yahoo.com logoEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain Compliance with the Market Value of Listed Securities Continued Listing Requirement
finance.yahoo.com - June 6 at 9:48 AM
finance.yahoo.com logoEloxx Pharmaceuticals Plans To Take ELX-02 Into Pivotal Trial For Alport Syndrome
finance.yahoo.com - May 24 at 2:40 PM
markets.businessinsider.com logoPhathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
markets.businessinsider.com - May 24 at 1:25 PM
finance.yahoo.com logoEloxx Pharmaceuticals Intends to Advance ELX-02 into Pivotal Trial for the Treatment of Alport Syndrome with Nonsense Mutations Following Achievement of Remission in Patient in Phase 2 Study
finance.yahoo.com - May 24 at 8:25 AM
marketwatch.com logoEloxx Pharmaceuticals Shares Plummet 34% Following 1Q Results
marketwatch.com - May 16 at 6:13 PM
msn.com logoWhy Is Eloxx Pharmaceuticals (ELOX) Stock Down 27% Today?
msn.com - May 16 at 9:49 AM
benzinga.com logoEloxx Pharmaceuticals shares are trading lower after the company reported worse-than-expected Q1 EPS results.
benzinga.com - May 16 at 9:49 AM
marketbeat.com logo
marketbeat.com - May 16 at 9:44 AM
finance.yahoo.com logoEloxx Pharmaceuticals, Inc. (ELOX) stock forecast and price target
finance.yahoo.com - May 16 at 12:46 AM
seekingalpha.com logoEloxx Pharmaceuticals Non-GAAP EPS of -$2.88
seekingalpha.com - May 15 at 7:45 PM
Get Eloxx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.



ELOX Media Mentions By Week

ELOX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ELOX
News Sentiment

0.00

0.52

Average
Medical
News Sentiment

ELOX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ELOX Articles
This Week

1

1

ELOX Articles
Average Week

Get Eloxx Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELOX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ELOX) was last updated on 2/20/2024 by MarketBeat.com Staff